Still uncomfortable with IL-6i in GCA or PMR especially given the pt population and potential AE? Be on the look out for
Tweet Content
Still uncomfortable with IL-6i in GCA or PMR especially given the pt population and potential AE?
Be on the look out for NEW biologics!
Mavrilimumab
Secukinumab
and MORE!
@RheumNow #ACR23 https://t.co/gdcDIcvffa
Show on Archive Page
On
Display in Search Results
On
PDQ
Off